Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 9.03% |
| Q2 2025 | -28.23% |
| Q1 2025 | -20.22% |
| Q4 2024 | 15.99% |
| Q3 2024 | 44.91% |
| Q2 2024 | -102.86% |
| Q1 2024 | 15.02% |
| Q4 2023 | -0.12% |
| Q3 2023 | 38.63% |
| Q2 2023 | -49.65% |
| Q1 2023 | -9.90% |
| Q4 2022 | -2.55% |
| Q3 2022 | 10.37% |
| Q2 2022 | -55.39% |
| Q1 2022 | -1.64% |
| Q4 2021 | 30.96% |
| Q3 2021 | -31.12% |
| Q2 2021 | -45.14% |
| Q1 2021 | -48.00% |
| Q4 2020 | -108.43% |
| Q3 2020 | -46.20% |
| Q2 2020 | 7.00% |
| Q1 2020 | 17.66% |
| Q4 2019 | -29.40% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |